Stock Taper
SCREENER COMPARE ANY 2 STOCKS
EXCHANGE TRADED FUND

XPH

State Street SPDR S&P Pharmaceuticals ETF
$70.79 ▼ 2.24%
−$1.62 TODAY

FUND FACTS

Manager SPDR
Assets $583.15M
Expense ratio 0.35%
Inception Jun 19, 2006
Asset class Equity
Holdings 64
Volume 262.45K
Avg volume 87.97K

ABOUT THIS FUND

SPDR Series Trust - SPDR S&P Pharmaceuticals ETF is an exchange traded fund launched by State Street Global Advisors, Inc. It is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. The fund invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Pharmaceuticals Select Industry Index, by using representative sampling technique. SPDR Series Trust - SPDR S&P Pharmaceuticals ETF was formed on June 16, 2006 and is domiciled in the United States.

PRICE

$70.79 ▼ DOWN 2.24% (−$1.62)
$71.00$71.50$72.009:33 AM10:37 AM11:42 AM12:46 PM1:50 PM2:55 PM3:59 PM70.79

HOLDINGS

TOP 20 OF 64 · 45.05% OF THE FUND
RANK STOCK WEIGHT SHARES VALUE
01 AMLX Amylyx Pharmaceuticals, Inc. 3.93% 619.56K $23.03M
02 CRNX Crinetics Pharmaceuticals, Inc. 3.51% 242.99K $20.61M
03 MBX MBX Biosciences, Inc. Common Stock 3.04% 269.1K $17.86M
04 ATAI Atai Beckley Inc. 2.76% 2.21M $16.21M
05 OMER Omeros Corporation 2.68% 817.58K $15.73M
06 DFTX Definium Therapeutics, Inc. 2.68% 358.83K $15.72M
07 ELVN Enliven Therapeutics, Inc. 2.32% 225.39K $13.63M
08 NUVB Nuvation Bio Inc. 2.17% 1.82M $12.72M
09 CORT Corcept Therapeutics Incorporated 2.13% 106.75K $12.48M
10 ETON Eton Pharmaceuticals, Inc. 2.10% 196.98K $12.34M
11 EWTX Edgewise Therapeutics, Inc. 1.91% 253.32K $11.19M
12 TRVI Trevi Therapeutics, Inc. 1.90% 622.34K $11.17M
13 NKTR Nektar Therapeutics 1.87% 146.87K $10.95M
14 PRGO Perrigo Company plc 1.79% 746.58K $10.51M
15 MRK Merck & Co., Inc. 1.78% 70.03K $10.47M
16 OCUL Ocular Therapeutix, Inc. 1.76% 954.15K $10.32M
17 BMY Bristol-Myers Squibb Company 1.71% 149.99K $10.04M
18 AMRX Amneal Pharmaceuticals, Inc. 1.67% 544.34K $9.8M
19 TARS Tarsus Pharmaceuticals, Inc. 1.67% 136.11K $9.79M
20 MAZE Maze Therapeutics, Inc. 1.65% 339.07K $9.69M

SECTOR HOLDINGS

TECHNOLOGY IS 100.00% OF THE FUND
Healthcare 100.00%

BY REGION

UNITED STATES IS 96.56% OF THE FUND
United States 96.56%
Ireland 3.35%
— Other 0.09%